JMP Cuts Pharmasset (VRUS) to Market Perform
Tweet Send to a FriendGet Alerts VRUS Hot Sheet
Price: $136.97 --0%
Rating Summary:
5 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 24 | Down: 17 | New: 24
Rating Summary:
5 Buy, 10 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 24 | Down: 17 | New: 24
Trade VRUS Now!
JMP Securities' Liisa Bayko just downgraded shares of Pharmasset (NASDAQ: VRUS) from Market Outperform to Market Perform in an intraday research note.
The stock is down more than 6 percent this afternoon following the addition of four new arms to its PSI-7977 Phase IIa trial.
For more ratings news on Pharmasset click here and for the rating history of Pharmasset click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The stock is down more than 6 percent this afternoon following the addition of four new arms to its PSI-7977 Phase IIa trial.
For more ratings news on Pharmasset click here and for the rating history of Pharmasset click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades SunTrust Banks (STI) to Neutral
- UPDATE: Global Equities Starts Tesla Motors (TSLA) at Overweight
- Jefferies Downgrades Infinera Corp. (INFN) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP Securities
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
